![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Acknowledgements
The authors would like to thank research nurses Tina Sørensen and Cathrine Wolf Lorenzen for their assistance in treatment and follow up. This work did not employ writing assistance.
Ethical approval
The CaEP-B study protocol is approved by the European Union Drug Regulating Authorities (EudraCT no: 2019-004315-31), the Danish Data Protection Agency (REG-114-2019) and Ethics committee for Region Zealand (SJ-811) and registered on Clinicaltrials.gov (NCT04259658). The trial is performed according to Good Clinical Practice (GCP). Clinicaltrials.gov identifier: NCT04259658.
Author contributions
MV was the primary author of the manuscript and performed data curation and data visualisation. MV and JG treated the patient and curated data. LML curated data and performed photo documentation, AJC managed patient treatment and relevant sections in the manuscript. LÖ analysed images and SP and AVL performed histological analyses. All authors read and approved the final manuscript.
Disclosure statement
JG is co-inventor of a patent regarding calcium electroporation: Therapeutic applications of calcium electroporation to effectively induce tumour necrosis. Granted. PCT/DK2012/050496. No other authors declare any conflict of interest.
Data availability statement
De-identified participant data are available from the corresponding author upon reasonable request. Reuse of data requires approval from the pertinent ethics committee.
Consent for publication
In addition to securing written and oral consent for participation in the CaEP-B trial, the authors also obtained signed informed consent specifically for the publication of the case report. This consent encompasses the inclusion of photographs and PET-CT images.